Please use this identifier to cite or link to this item:
https://bura.brunel.ac.uk/handle/2438/34137Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bloom, Chloe I | - |
| dc.contributor.author | Middleton, Jack | - |
| dc.contributor.author | Lewis, Adam | - |
| dc.date.accessioned | 2026-11-07T14:02:14Z | - |
| dc.date.available | 2026-11-07T14:02:14Z | - |
| dc.date.issued | 2025-02-03 | - |
| dc.identifier.citation | Bloom, C.I., Middleton, J. and Lewis, A. (2025) 'Qualitative study of patients experiences and perceptions of stepping down asthma medication in primary care across England', BMJ Open Respiratory Research, 12(1), e002898, pp. 1–9. doi: 10.1136/bmjresp-2024-002898. | en_US |
| dc.identifier.issn | 2052-4439 | - |
| dc.identifier.uri | https://bura.brunel.ac.uk/handle/2438/34137 | - |
| dc.description | Data availability statement: Data are available upon reasonable request. All data relevant to the study are included in the article or uploaded as supplementary information. | en_US |
| dc.description | Supplementary files are available online at: https://bmjopenrespres.bmj.com/content/12/1/e002898#supplementary-materials . | en_GB |
| dc.description.abstract | Background: Guidelines recommend that asthma medication should be stepped down to the minimally effective dose that achieves symptom control. Stepping down aims to prevent adverse medication effects and unnecessary costs but is often not implemented in primary care, where most patients with asthma are managed. Little is known about the experiences and views of patients regarding stepping down. Methods: Patients with stable asthma, with regular use of a preventer inhaler, from general practitioner practices across England, participated in a survey and/or semi-structured interview. Questions explored the patient’s understanding of their asthma, views and knowledge of preventer inhalers, experiences and perceptions of stepping down asthma medication. Qualitative group-based multidisciplinary thematic analysis by two healthcare professionals and a patient were performed. Results: 143 patients responded to the survey, 63% were female, between the ages 18–80 years and including geographical areas across the UK, 17 of whom participated in an interview. Half of these patients with stable asthma, most with asthma for more than 10 years, had never had a discussion regarding stepping down asthma medication. Most stepping down that had occurred was related to seasonal changes in asthma control. Four overarching themes from the interviews were identified, (1) experiences of living with asthma and needing inhalers, (2) insufficient education regarding preventer inhalers, (3) stepping down is agreeable and possible and (4) current asthma care is suboptimal. Conclusion: Patients with stable asthma were able to self-manage their asthma well. They had little awareness of medication adverse effects and minimal experience of having their medication stepped down by a healthcare professional. Most were inclined to step down, if clinically safe to do so, indeed some had reduced their medication doses themselves, without professional guidance. | en_US |
| dc.description.sponsorship | National Institute for Health and Social Care Research, Advanced Fellowship, award number 301726 | en_US |
| dc.format.extent | pp. 1–9 | - |
| dc.format.medium | Electronic | - |
| dc.language | English | en_GB |
| dc.language.iso | en | en_GB |
| dc.publisher | BMJ Publishing Group on behalf of British Thoracic Society | en_GB |
| dc.rights | Re-use licence for this version: Creative Commons Attribution 4.0 International | - |
| dc.rights | Licence for published version: Creative Commons Attribution 4.0 International | - |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
| dc.subject | asthma | en_GB |
| dc.subject | asthma epidemiology | en_GB |
| dc.subject.mesh | Humans | - |
| dc.subject.mesh | Asthma | - |
| dc.subject.mesh | Anti-Asthmatic Agents | - |
| dc.subject.mesh | Administration, Inhalation | - |
| dc.subject.mesh | Nebulizers and Vaporizers | - |
| dc.subject.mesh | Health Knowledge, Attitudes, Practice | - |
| dc.subject.mesh | Qualitative Research | - |
| dc.subject.mesh | Adolescent | - |
| dc.subject.mesh | Adult | - |
| dc.subject.mesh | Aged | - |
| dc.subject.mesh | Aged, 80 and over | - |
| dc.subject.mesh | Middle Aged | - |
| dc.subject.mesh | Primary Health Care | - |
| dc.subject.mesh | England | - |
| dc.subject.mesh | Female | - |
| dc.subject.mesh | Male | - |
| dc.subject.mesh | Young Adult | - |
| dc.subject.mesh | Surveys and Questionnaires | - |
| dc.subject.mesh | Humans | - |
| dc.subject.mesh | Asthma | - |
| dc.subject.mesh | Female | - |
| dc.subject.mesh | Male | - |
| dc.subject.mesh | Adult | - |
| dc.subject.mesh | England | - |
| dc.subject.mesh | Middle Aged | - |
| dc.subject.mesh | Primary Health Care | - |
| dc.subject.mesh | Aged | - |
| dc.subject.mesh | Qualitative Research | - |
| dc.subject.mesh | Anti-Asthmatic Agents | - |
| dc.subject.mesh | Young Adult | - |
| dc.subject.mesh | Adolescent | - |
| dc.subject.mesh | Aged, 80 and over | - |
| dc.subject.mesh | Health Knowledge, Attitudes, Practice | - |
| dc.subject.mesh | Administration, Inhalation | - |
| dc.subject.mesh | Nebulizers and Vaporizers | - |
| dc.subject.mesh | Surveys and Questionnaires | - |
| dc.title | Qualitative study of patients experiences and perceptions of stepping down asthma medication in primary care across England | en_GB |
| dc.type | Article | en_GB |
| dc.date.dateAccepted | 2024-12-05 | - |
| dc.identifier.doi | https://doi.org/10.1136/bmjresp-2024-002898 | - |
| dc.relation.isPartOf | BMJ Open Respiratory Research | en_GB |
| pubs.issue | 1 | - |
| pubs.publication-status | Published | - |
| pubs.volume | 12 | - |
| dc.identifier.eissn | 2052-4439 | - |
| dc.rights.license | https://creativecommons.org/licenses/by/4.0/legalcode.en | - |
| dcterms.dateAccepted | 2024-12-05 | - |
| dcterms.description | What is already known on this topic: • Many patients are managed with higher doses of asthma medication than required. Our previous study explored the barriers for healthcare professionals to step-down asthma medication, here we explore for the first time, the experiences and perceptions of patients. What this study adds: • Patients are amenable and keen to step down their asthma medication doses, when clinically appropriate. • How this study might affect research, practice or policy Patient willingness should not be a barrier to stepping down; primary care clinical trials and clear guidelines on how to step down are needed to prevent the overuse of asthma medication. | en_GB |
| dcterms.issued | 2025-02-03 | - |
| dc.date.updated | 2026-11-07T13:31:36Z | - |
| dc.rights.holder | Author(s) (or their employer(s) | - |
| dc.contributor.orcid | Bloom, Chloe I [0000-0003-1285-7602] | - |
| dc.contributor.orcid | Lewis, Adam [0000-0002-0576-8823] | - |
| dc.identifier.number | e002898 | - |
| Appears in Collections: | Department of Health Sciences Research Papers | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| FullTime.pdf | Copyright © Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group. This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/). | 259.99 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License